Everhart Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-512
| Closed | -$325K | – | 352 |
|
|
2025
Q1 | $325K | Buy |
512
+160
| +45% | +$101K | 0.04% | 270 |
|
|
2024
Q4 | $251K | Sell |
352
-508
| -59% | -$362K | 0.05% | 278 |
|
|
2024
Q3 | $904K | Buy |
860
+310
| +56% | +$326K | 0.2% | 112 |
|
|
2024
Q2 | $578K | Buy |
550
+71
| +15% | +$74.6K | 0.15% | 141 |
|
|
2024
Q1 | $461K | Buy |
479
+68
| +17% | +$65.4K | 0.13% | 158 |
|
|
2023
Q4 | $361K | Buy |
411
+23
| +6% | +$20.2K | 0.13% | 151 |
|
|
2023
Q3 | $319K | Buy |
388
+45
| +13% | +$37K | 0.14% | 148 |
|
|
2023
Q2 | $246K | Buy |
343
+23
| +7% | +$16.5K | 0.1% | 177 |
|
|
2023
Q1 | $263K | Buy |
320
+40
| +14% | +$32.9K | 0.12% | 158 |
|
|
2022
Q4 | $202K | Sell |
280
-104
| -27% | -$75K | 0.1% | 174 |
|
|
2022
Q3 | $264K | Buy |
+384
| New | +$264K | 0.15% | 144 |
|